Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study

G Westman

首页> 外文期刊>Breast Cancer Research >Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study

【24h】

Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study

机译：赫赛汀（曲妥珠单抗）在过度表达Her-2且对于晚期乳腺癌的多种化疗方案均无效的患者中：一项务实的研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Breast Cancer Research》 |2000年第1期|共页
作者
G Westman;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and tolerability of taxanes or vinorelbine chemotherapy with trastuzumab as a first combination in Her-2 overexpressing patients with metastatic breast cancer [J] . I.Glogowska, Sienkiewicz-Kozlowska, E.Szombara, European Journal of Cancer Supplements . 2006,第2期

机译：紫杉烷类药物或长春瑞滨化疗联合曲妥珠单抗作为Her-2过表达转移性乳腺癌患者的第一个组合的疗效和耐受性
2. Phase II study of Docetaxel, Carboplatin, and Trastuzumab (THC) as first-line treatment in patients with HER-2 amplified advanced breast cancer. Changes in circulating tumor cells (CTC), total plasma DNA and circulating HER-2 ECD [J] . L.Dirix, Benoy, A.Prové, European Journal of Cancer Supplements . 2006,第2期

机译：多西他赛，卡铂和曲妥珠单抗（THC）作为HER-2扩增晚期乳腺癌患者的一线治疗的II期研究。循环肿瘤细胞（CTC），血浆总DNA和循环HER-2 ECD的变化
3. Predictive value of activated tyrosine kinase (Tyr1248) in patients with HER2-overexpressing metastatic breast cancer (MBC) treated with trastuzumab + chemotherapy regimens [J] . R.Giuliani, M.Paesmans, V.Durbecq, European Journal of Cancer Supplements . 2004,第3期

机译：曲妥珠单抗+化疗方案对活化的酪氨酸激酶（Tyr1248）在HER2高表达转移性乳腺癌（MBC）患者中的预测价值
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. Molecular Imaging as a Tool for Predicting and Monitoring Response of Breast Cancer to Trastuzumab (Herceptin). [D] . McLarty, Kristin. 2009

机译：分子成像作为预测和监测乳腺癌对曲妥珠单抗（赫赛汀）反应的工具。
6. Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study [O] . G Westman 2000

机译：赫赛汀（曲妥珠单抗）在过度表达Her-2且对于晚期乳腺癌的多种化疗方案均无效的患者中：一项务实的研究
7. Erratum to: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy [O] . Elisabetta Munzone, Giuseppe Curigliano, Andrea Rocca, 2006

机译：错误：在暴露于曲妥珠单抗化疗的Her-2过表达先进的乳腺癌患者中，改善雌激素受体阴性表型

Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study

著录项

相似文献

相关主题

期刊订阅